|
TFG Experience
Lester has been Partner at TFG since 1998 and has had the pleasure of advising and managing on a broad range of engagements including global business strategies, global franchise development, market entry/commercialization planning, clinical portfolio planning and target product profile assessments, channel/provider strategies, disease management initiatives, market assessment/segmentation, industry supply-demand analyses, licensing and business development, venture capital investment due diligence, and trade/patient association strategies. Over the years, he has immersed himself in the key issues and dynamics across multiple therapeutic areas, including oncology, respiratory/allergy, infectious diseases, diabetes/metabolics, neurology, psychiatry, cardiovascular, dermatology, rheumatology, hematology, and immunology. During the past several years, he has had the opportunity to investigate a breadth of technology platforms as well, including drug delivery, diagnosis/monitoring devices, R&D enablers/tools in addition to macromolecules/biologic products. Client relationships have ranged from pharma to biotech to device/diagnostics to generic companies. Other healthcare clients have included trade organizations, patient advocacy groups, and venture capital. Examples of Lester's recent experience include 1) an analysis of the opportunities and drivers of success within the emerging generic injectable, oncology and biologic product categories, 2) multiple target product profile assessments and prioritization for a portfolio of CNS products for a development stage company, 3) a long term franchise strategy in inflammation and immunology for a top global pharmaceutical company, 4) a pharmaceutical trade channel analysis and strategic implications assessment for a top 5 pharmaceutical company and 5) a pediatric franchise engagement for a specialty pharmaceutical company.
Pre-TFG Experience
Prior to joining TFG, Lester was at Schering-Plough Corporation in their Oncology Biotech Division. His tenure at Schering included launching the Hepatitis indications for INTRON A, business development analyses and disease management opportunity assessments and program development. Prior to that, he was in field sales with Marion Laboratories.
Education
Lester holds a BS with honors in Biochemistry from Lehigh University and an MBA with honors in Marketing and International Business from Columbia Business School.
| 